Food restriction and hypoinsulinemia can affect the synthesis, turnover, and receptor function of serotonin (5-HT) in brain. This study explored the effects of food restriction and streptozotocin treatment on behavioral effects related to 5-HT 1A ( + )-8-hydroxy-2-(dipropylamino)tetralin hydrobromide (8-OH-DPAT) and 5-HT 2A [( ± )-2,5-dimethoxy-4-iodoamphetamine hydrochloride (DOI)] receptor activation. Lower lip retraction and flat body posture (8-OH-DPAT) and head twitching (DOI) were measured in rats during free feeding, food restriction, after treatment with streptozotocin, and finally after insulin replacement. 8-OH-DPAT induced lower lip retraction and flat body posture whereas DOI induced head twitching. One week of food restriction (10 g/day) decreased 8-OH-DPAT-induced lower lip retraction, 8-OH-DPAT-induced flat body posture, and DOI-induced head twitching. Subsequently, 1 week of free access to food restored sensitivity to 8-OH-DPAT and DOI-induced behavioral effects. Finally, 1 week after streptozotocin, 8-OH-DPAT-induced flat body posture and DOI-induced head twitching were markedly reduced whereas 8-OH-DPAT-induced lower lip retraction was unchanged. One week of insulin replacement restored sensitivity to 8-OH-DPAT and DOI-induced behavioral effects. These results show that modest food restriction or experimentally induced diabetes can profoundly affect sensitivity to drugs acting at 5-HT 1A or 5-HT 2A receptors; these results could be relevant to understanding the comorbidity of depression and diabetes.
Food restriction and streptozotocin treatment decrease 5-HT 1A and 5-HT 2A receptor-mediated behavioral effects in rats Introduction Serotonin (5-HT) plays a major role in regulating a wide variety of physiologic and behavioral processes including food intake; conversely, nutritional status can regulate the activity of 5-HT systems. For example, 5-HT neurons in the median raphe nucleus modulate ingestive behavior (Wirtshafter, 2001) ; and in normal animals, stimulation of 5-HT 2C or 5-HT 1B receptors can cause hypophagia whereas stimulation of 5-HT 1A and 5-HT 2B receptors can cause hyperphagia (De Vry and Schreiber, 2000) . In contrast, food restriction can decrease 5-HT concentration and rate of synthesis in brain (Haleem and Haider, 1996; Haider and Haleem, 2000) , downregulate the density of 5-HT transporters in frontal cortex (Huether et al., 1997) , and decrease the expression of 5-HT 1B receptors in hypothalamus (Gur et al., 2003) . The functional consequences of these changes in 5-HT neurotransmission are not fully understood, although diet-induced changes in the sensitivity of 5-HT systems in the brain could have important implications for the therapeutic use of many drugs.
Diabetics have a higher prevalence of major depression and depressive symptoms, as compared with nondiabetics , and experimentally induced diabetes can dramatically alter sensitivity to drugs acting on certain monoamine transporters and receptors [e.g. dopamine (Sevak et al., 2007) ]. Indeed, the comorbidity of depression and diabetes could be related to the same underlying changes in dopaminergic and other neurotransmitter systems. Given the importance of 5-HT in the pathogenesis and treatment of various psychiatric disorders, it might also be the case that sensitivity to drugs acting on 5-HT systems would be similarly altered by diabetes. Although in rats streptozotocin (STZ)induced diabetes increases cortical 5-HT 2A receptor density (Sumiyoshi et al., 1997) , sensitivity to ( ± )-2,5dimethoxy-4-iodoamphetamine hydrochloride (DOI) (a 5-HT 2A/2C receptor agonist)-induced wet-dog shakes is not changed (Amano et al., 2007) . In contrast, experimentally induced diabetes reportedly attenuates the antidepressant-like effects of the 5-HT 1A receptor agonist ( + )-8-hydroxy-2-(dipropylamino)tetralin hydrobromide in the mouse tail suspension test (Miyata et al., 2004a) . To further study the relationship among food intake, insulin status, and sensitivity of monoaminergic systems, this experiment examined sensitivity to the behavioral effects of direct acting 5-HT receptor agonists in rats under four conditions: free feeding, food restricted, diabetic, and diabetic with insulin replacement.
Methods

Subjects
Eleven adult male Sprague-Dawley rats (Harlan, Indianapolis, Indiana, USA) were housed individually on a 12/12-h light/dark cycle (experiments were conducted during the light period) with free access to water in the home cage. Except for 1 week of limited access (10 g/day) to food, all animals had free access to food in the home cage. All animals were maintained and experiments were conducted in accordance with the Institutional Animal Care and Use Committee, The University of Texas Health Science Center at San Antonio, and with the 1996 Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources on Life Sciences, National Research Council, National Academy of Sciences, Washington DC, USA).
Experimental design
Activation of certain subtypes (e.g. 5-HT 1A ) of 5-HT receptors can produce a characteristic behavioral response comprising lower lip retraction, flat body posture, and forepaw treading; the current study examined lower lip retraction and flat body posture after administration of the 5-HT 1A receptor agonist 8-OH-DPAT. Activation of another 5-HT receptor subtype (5-HT 2A ) can increase head twitching; this study also examined head twitching after the administration of the 5-HT 2A receptor agonist DOI. Tests were conducted in the home cage and all rats were tested under all conditions. For 8-OH-DPAT a cumulative dosing procedure was used with rats receiving vehicle (intraperitoneally) before the first 10-min cycle, followed by increasing doses of drug (intraperitoneally) every 10 min, with the cumulative dose increasing by 0.5 log unit per injection. Lower lip retraction [i.e. when the lower incisors were visible (Berendsen et al., 1989) ] and flat body posture [when the entire ventral surface of the body was in contact with the cage floor (Colpaert et al., 1989) ] were monitored and recorded as present or absent during the last minute of each 10-min cycle. Three doses of DOI (0.32, 1.0, and 3.2 mg/kg) were studied on three consecutive days with the order of testing randomized among animals. For a test, rats received vehicle (intraperitoneally) and head twitching was counted for 20 min; rats then received an injection of DOI and head twitching was counted for another 20 min. A head twitch was defined as spontaneous (not stimulated), irregularly occurring horizontal head movement, resembling a strong pinna reflex and involving the whole head (Corne et al., 1963) .
After these effects of 8-OH-DPAT (day 1) and DOI (days 2-4) were measured, access to food was restricted to 10 g/day for 7 days; on days 12-15 the same tests were repeated with the same drugs in all food-restricted rats. To confirm that any changes in sensitivity to 8-OH-DPAT and DOI were because of food restriction, free feeding was resumed and after 7 days the same tests were repeated with 8-OH-DPAT and DOI.
Next, all rats were rendered diabetic by an intraperitoneal injection of 50 mg/kg of STZ. One week after the administration of STZ (day 8-11), the same tests were conduced with 8-OH-DPAT and DOI. The next day (12 days after the administration of STZ), two insulin pellets (i.e. Linplant) were surgically implanted (subcutaneously) under ketamine (36 mg/kg intramuscularly) and xylazine (4.8 mg/kg intramuscularly) anesthesia. Beginning 10 days after the insertion of Linplant pellets (i.e. 22 days after STZ), the same drugs were tested a final time over 4 consecutive days. Body weights were measured daily throughout the study. Drugs 8-OH-DPAT and STZ were purchased from Sigma-Aldrich (St Louis, Missouri, USA). DOI was provided by the Research Technology Branch, National Institute of Drug Abuse (Rockville, Maryland, USA). Linplant pellets (i.e. sustained release insulin implants) were purchased from LinShin Canada Inc. (Scarborough, Ontario, Canada). According to the manufacturer, each Linplant releases 2 U of insulin over 24 h for at least 40 days (Wang, 1991) . Except for ketamine hydrochloride and xylazine hydrochloride, both of which were purchased as commercially available solutions (Vetus Animal Health, Burns Veterinary Supply Inc., Westbury, New York, USA), drugs were dissolved in sterile 0.9% saline. STZ solutions were prepared immediately before administration. Injection volumes were 0.2-1.0 ml.
Data analyses
For studies with 8-OH-DPAT, dose-response functions were determined for the percentage of rats showing lower lip retraction or flat body posture after each dose. Effective dose (ED 50 ) values were estimated using liner regression and 95% confidence limits were calculated. The data were further analyzed by fitting straight lines to the individual dose-response data by means of GraphPad Prism version 5.0 for Windows (GraphPad Software, Inc., San Diego, California, USA), using the following equation: effect = slope Â log(dose) + intercept. For these analyses, only the linear portion of the dose-effect curve was used, defined by doses producing 25-75% of the maximum possible effect, including not more than one dose producing less than 25% and not more than one dose producing more than 75% of the maximum possible effect. Other doses were excluded from the analyses. The slopes and intercepts of dose-response functions for each condition were compared with an F-ratio test using GraphPad; two conditions were considered to be significantly different when the data sets could not be described with a single line.
For studies with DOI, data were analyzed with separate two-way analyses of variance (ANOVA) for repeated measures with one factor comprising treatment (control, Feeding, insulin and serotonin Li and France 293 food restriction, food replacement, STZ treatment, and insulin replacement) and a second factor comprising dose (P < 0.05). A post-hoc Tukey-Kramer test was used to examine significant differences among treatments (P < 0.05). Body weights were analyzed using a onefactor (days after STZ) ANOVA, followed by Dunnett's two-sided tests.
Results
Effects of food restriction on 8-OH-DPAT and DOI-induced behavioral effects 8-OH-DPAT dose-dependently increased the incidence of lower lip retraction with all 11 rats showing lower lip retraction after receiving a dose of 0.32 mg/kg [ED 50 (95% confidence limits) = 0.053 mg/kg (0.027, 0.081); circles, upper panels, Fig. 1 ]. 8-OH-DPAT also dose-dependently increased the percentage of rats showing flat body posture [ED 50 = 0.120 mg/kg (0.077, 0.162); circles, lower panels, Fig. 1 ]. DOI dose-dependently increased the frequency of head twitching with doses of 0.32, 1.0, and 3.2 mg/kg producing averages of 2.2 ± 0.6, 10.4 ± 2.4, and 16.2 ± 2.3 twitches, respectively, in a 20-min observation period (circles, Fig. 2 ).
One week of food restriction significantly decreased the sensitivity of rats to 8 After 1 week of free feeding rats showed normal sensitivity to 8-OH-DPAT-induced lower lip retraction [ED 50 = 0.041 mg/kg (0.029, 0.053); inverted triangles, upper left panel, Fig. 1 ] and 8-OH-DPAT-induced (1) control conditions (i.e. during free access to food and before food restriction; circles); (2) during food restriction (10 g/day; triangles); (3) after resumption of free access to food (inverted triangles); (4) after receiving 50 mg/kg of streptozotocin [(STZ) squares]; and (5) after insulin replacement (diamonds). Horizontal axes: dose in mg/kg body weight. 'V' indicates vehicle. ( ± )-2,5-Dimethoxy-4-iodoamphetamine hydrochloride (DOI)-induced head twitching in the same 11 rats (Fig. 1) under the same five conditions: (1) control conditions (i.e. during free access to food and before food restriction; circles); (2) during food restriction (10 g/day; triangles); (3) after resumption of free access to food (inverted triangles); (4) after receiving 50 mg/kg of streptozotocin [(STZ) squares]; and (5) flat body posture [ED 50 = 0.094 mg/kg (0.051, 0.137); inverted triangles, lower left panel, Fig. 1 ]. In each case, the linear portion of the dose-response curves for 8-OH-DPAT-induced lower lip retraction and flat body posture, under control and food replacement conditions, could be fitted with a common slope and a common intercept, indicating that the dose-response curves were not significantly different. Sensitivity to DOI-induced head twitching also was restored after 1 week of free access to food (P > 0.05; inverted triangles, left panel, Fig. 2 ).
Effects of STZ on 8-OH-DPAT and DOI-induced behavioral effects
One week after the administration of STZ, the sensitivity of rats to 8 Ten days after the implantation of insulin pellets, rats showed normal sensitivity to 8-OH-DPAT-induced lower lip retraction [ED 50 = 0.041 mg/kg (0.029, 0.053); diamonds, upper right panel, Fig. 1 ] and 8-OH-DPATinduced flat body posture [ED 50 = 0.125 mg/kg (0.085, 0.164); diamonds, lower right panel, Fig. 1 ]. In each case, the linear portion of the dose-response curves for 8-OH-DPAT-induced lower lip retraction and flat body posture, under control and insulin replacement conditions, could be fitted with a common slope and a common intercept, indicating that the dose-response curves were not significantly different. Sensitivity of STZ-treated rats to DOI-induced head twitching also was restored by insulin replacement (P > 0.05; diamonds, right panel, Fig. 2) .
STZ significantly decreased body weight over days [F(22,220) = 3.17; P < 0.001; Fig. 3 ]. After insulin replacement body weight increased progressively across days. For example, 8 days after insulin replacement (i.e. 20 days after STZ), average body weight (378.3 ± 6.8 g) was not different from the average body weight before STZ (i.e. day 0; 379.7 ± 4.2 g). Rats continued to gain body weight for the remainder of the study (Fig. 3 ).
Discussion
Limited access to food or experimentally induced diabetes can dramatically alter the behavioral and neurochemical effects of drugs acting on dopaminergic systems (e.g. Sevak et al., 2007) and this study investigated whether food restriction or diabetes also modifies drugs acting on 5-HT systems. The major finding from this study is that results obtained with 5-HT receptor agonists are similar to those reported for dopamine receptor agonists, insofar as both food restriction and experimentally induced diabetes markedly decrease sensitivity to drugs acting selectively either at 5-HT 1A or 5-HT 2A receptors. Free access to food and insulin replacement, respectively, restored normal sensitivity to both 5-HT receptor agonists, suggesting that nutrition and insulin status might be especially important in modulating the activity of 5-HT systems and, therefore, in modifying sensitivity to drugs acting on those systems.
Activation of 5-HT receptors, by various different mechanisms, can produce a characteristic behavioral response comprising lower lip retraction, flat body Body weight (g) in the same 11 rats (Figs 1 and 2) that received streptozotocin (STZ) on day 0 and insulin replacement on day 12; rats had free access to food throughout this component of the study. Each data point represents the mean ± SEM for 11 rats. *P < 0.05 compared with day 0.
Feeding, insulin and serotonin Li and France 295 posture, and forepaw treading; these effects are used routinely to study drugs acting on 5-HT systems, including direct-acting receptor agonists. In particular, drugs with agonist activity at 5-HT 1A receptors reliably produce lower lip retraction, which is thought to be mediated by presynaptic 5-HT 1A receptors (Berendsen et al., 1989 (Berendsen et al., , 1994 , and flat body posture, which is thought to be mediated by postsynaptic 5-HT 1A receptors (Tricklebank et al., 1984) . That food restriction seems to attenuate 8-OH-DPAT-induced flat body posture more than 8-OH-DPAT-induced lower lip retraction suggests that food restriction is more effective in modifying the sensitivity of rats to drugs acting at postsynaptic as compared with presynaptic 5-HT 1A receptors. Although 8-OH-DPAT also has agonist activity at other (e.g. 5-HT 7 ) receptors (Hedlund et al., 2004) , there is no clear evidence to suggest that 8-OH-DPAT-induced lower lip retraction or flat body posture are mediated by the activation of those receptors. In an earlier study, 24-h food deprivation did not affect either binding to or sensitivity of presynaptic 5-HT 1A receptors (Chaouloff et al., 1997) . Thus, diet-induced changes in 5-HT receptor sensitivity might occur selectively for different subtypes of 5-HT receptors. It is clear from this study that just 1 week of food restriction markedly decreases the sensitivity of rats to behavioral effects that are presumed to be mediated by 5-HT 1A receptors, although it is not clear whether these diet-induced changes are because of altered receptor number, sensitivity, secondmessage signaling, or to other factors.
Activation of another subtype (5-HT 2A ) of 5-HT receptor can increase head twitching and this behavioral effect also is used widely to study the actions of drugs acting at 5-HT receptors. DOI reliably increased head twitching in normal rats and this effect was markedly decreased by food restriction and nearly eliminated by the administration of STZ. Sensitivity to DOI-induced head twitching was restored by free access to food and by insulin replacement, respectively. These results provide yet another example of the rapid and marked changes in sensitivity to druginduced behavioral effects that can occur after modest food restriction or after the experimental induction of diabetes. To the extent that therapeutic or abuse-related effects of drugs are mediated by 5-HT 2A receptors, these data suggest that nutritional factors could play an important role in determining sensitivity to and effectiveness of some drugs.
STZ has been used extensively to induce diabetes and in some studies to examine the changes that occur in sensitivity to drugs acting at specific neurotransmitter receptors or transporters. A single injection of 50 mg/kg STZ reliably eliminates insulin-secreting pancreatic b-islet cells, thereby increasing blood glucose, decreasing body weight, and modifying the behavioral and neurochemical effects of drugs acting on dopamine systems (Galici et al., 2003; Sevak et al., 2007) . Similarly, in this study, STZ markedly decreased body weight that recovered rapidly after insulin replacement. In addition to well-documented changes in dopamine systems that occur after STZ treatment, experimentally induced diabetes also can lead to long-lasting changes in the activity of 5-HT systems. For example, 5-HT 1A receptor agonists have antidepressant-like effects in several animal models (Cervo and Samanin, 1987; McGrath and Norman, 1999) ; however, in mice, the antidepressantlike effects of 8-OH-DPAT are markedly attenuated by STZ (Miyata et al., 2004a) . Moreover, DOI is less effective in producing head twitching in mice that are treated with STZ (Miyata et al., 2004b) . Interestingly, the density and affinity of 5-HT 2A receptors are decreased in diabetic mice and can be restored by insulin replacement (Sumiyoshi et al., 1997; Jackson and Paulose, 1999) . In this study, both 8-OH-DPAT-induced flat body posture and DOI-induced head twitching were markedly reduced after STZ treatment. One determinant of brain tryptophan content is the concentration of circulating insulin, with increasing concentrations of insulin decreasing plasma concentrations of large neutral amino acids that normally compete with tryptophan for uptake into the brain (Curzon and Fernando, 1977) . Like food restriction, STZ can decrease the threshold for lateral hypothalamic self-administration (Carr, 1996) and it has been proposed that hypoinsulinemia (food restriction or experimentally induced diabetes) can modulate monoamine transporter gene expression (Carr et al., 2000) . For example, foodrestricted rats are less sensitive than control rats to insulin (Alonso et al., 2005) . Food restriction also decreases insulin secretion (Vuguin et al., 2001) and reduces plasma insulin-like growth factor-I in rats (Monaco and Donovan, 1997; Takenaka et al., 2000) . Thus, while it is not clear what mechanism(s) mediates changes in 5-HT function under different nutritional conditions, it is clear that at least some of these changes, which occur rapidly, are very robust, and are reversible. Given that one behavioral effect of 8-OH-DPAT was decreased (flat body posture) by STZ whereas another effect remained essentially unchanged (lower lip retraction), it seems unlikely that pharmacokinetic factors play a significant role in these results. It also seems unlikely that changes in general arousal contribute to these effects as experimentally induced diabetes often decreases whereas food restriction can increase or have no effect on locomotion (e.g. Sevak et al., 2007, unpublished observation) .
In summary, restricted access to food or experimentally induced diabetes can attenuate the sensitivity of rats to the behavioral effects of drugs acting (agonists) directly at 5-HT 1A or 5-HT 2A receptors. Together with earlier data showing similar decreased sensitivity to drugs acting at dopamine receptors, these results suggest that relatively modest changes in nutrition or insulin status could have profound effects on the effectiveness of drugs acting at monoaminergic receptors as well as other sites (e.g. transporters). Given the high comorbidity of diabetes and depression (De Groot et al., 2001; Ali et al., 2006; Barnard et al., 2006; Knol et al., 2006) and the apparent functional impact of food restriction on antidepressant effects of drugs in animals (Soubrié et al., 1989) , it will be important to better characterize how underlying changes in neurotransmission, in general, and receptor sensitivity, in particular, might contribute to the activity of antidepressants and other psychotherapeutics.
